Genomic and evolutionary characteristics of metastatic gastric cancer by routes

[1]  B. J. Kim,et al.  Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach , 2023, Journal of gastric cancer.

[2]  Yun Liu,et al.  Integrated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer , 2022, Cell Death & Disease.

[3]  K. Jung,et al.  Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019 , 2022, Cancer research and treatment.

[4]  I. Choi,et al.  A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines , 2022, Journal of gastric cancer.

[5]  Adrian V. Lee,et al.  Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis. , 2022, Cancer research.

[6]  F. Lordick,et al.  Primary and metastatic peritoneal surface malignancies , 2021, Nature Reviews Disease Primers.

[7]  R. Kordek,et al.  Intertumoral Heterogeneity of Primary Breast Tumors and Synchronous Axillary Lymph Node Metastases Reflected in IHC-Assessed Expression of Routine and Nonstandard Biomarkers , 2021, Frontiers in Oncology.

[8]  N. Navin,et al.  MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution , 2021, bioRxiv.

[9]  C. Swanton,et al.  Cancer evolution: Darwin and beyond , 2021, The EMBO journal.

[10]  David R. Jones,et al.  Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients , 2021, Cell.

[11]  Yuquan Wei,et al.  Genomic evolution and diverse models of systemic metastases in colorectal cancer , 2021, Gut.

[12]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[13]  E. Chow,et al.  Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age. , 2021, Trends in pharmacological sciences.

[14]  Erik N. Bergstrom,et al.  Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor , 2020, bioRxiv.

[15]  A. Gautreau,et al.  Mutational drivers of cancer cell migration and invasion , 2020, British journal of cancer.

[16]  David J. Sims,et al.  Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH) , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Nicolai J. Birkbak,et al.  Pervasive chromosomal instability and karyotype order in tumour evolution , 2020, Nature.

[18]  P. Rosenstiel,et al.  Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine , 2020, Genome medicine.

[19]  Arjun K Menta,et al.  Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer , 2020, Frontiers in Oncology.

[20]  Yoon Young Choi,et al.  A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer , 2020, Cancer research and treatment : official journal of Korean Cancer Association.

[21]  Johannes G. Reiter,et al.  Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases , 2020, Nature Genetics.

[22]  D. Tan,et al.  Mapping the spreading routes of lymphatic metastases in human colorectal cancer , 2020, Nature Communications.

[23]  Japanese Gastric Cancer Association.  Japanese gastric cancer treatment guidelines 2018 (5th edition) , 2020, Gastric Cancer.

[24]  Jianyong Sun,et al.  MSIsensor-pro: Fast, Accurate, and Matched-normal-sample-free Detection of Microsatellite Instability , 2020, Genom. Proteom. Bioinform..

[25]  N. Birkbak,et al.  Cancer Genome Evolutionary Trajectories in Metastasis. , 2020, Cancer cell.

[26]  J. Cheong,et al.  Clinical Implementation of Precision Medicine in Gastric Cancer , 2019, Journal of gastric cancer.

[27]  S. Hanash,et al.  Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response , 2019, Gut.

[28]  C. Curtis,et al.  Quantitative evidence for early metastatic seeding in colorectal cancer , 2019, Nature Genetics.

[29]  Edith M. Ross,et al.  The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer , 2019, Cell reports.

[30]  M. Egger,et al.  Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial , 2019, The Lancet.

[31]  M. Stratton,et al.  Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis , 2019, Cell.

[32]  Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach , 2019, Journal of gastric cancer.

[33]  M. Akhtar,et al.  Paget’s “Seed and Soil” Theory of Cancer Metastasis: An Idea Whose Time has Come , 2019, Advances in anatomic pathology.

[34]  Yoon Young Choi,et al.  Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy , 2018, BMC Cancer.

[35]  M. Stratton,et al.  Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma , 2018, bioRxiv.

[36]  S. Sleijfer,et al.  Pan-cancer whole-genome analyses of metastatic solid tumours , 2019, Nature.

[37]  Tae-Min Kim,et al.  Mutation heterogeneity between primary gastric cancers and their matched lymph node metastases , 2018, Gastric Cancer.

[38]  Ville Mustonen,et al.  The repertoire of mutational signatures in human cancer , 2018, Nature.

[39]  Benjamin J. Raphael,et al.  Inferring Parsimonious Migration Histories for Metastatic Cancers , 2018, Nature Genetics.

[40]  Steven J. M. Jones,et al.  Comprehensive Characterization of Cancer Driver Genes and Mutations , 2018, Cell.

[41]  J. DeGregori,et al.  Adaptive Oncogenesis: A New Understanding of How Cancer Evolves inside Us , 2018 .

[42]  Gustav Stålhammar,et al.  Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes , 2018, The Journal of clinical investigation.

[43]  A. Biondi,et al.  Krukenberg tumors: Seed, route and soil. , 2017, Surgical oncology.

[44]  Annalisa Capobianco,et al.  The peritoneum: healing, immunity, and diseases , 2017, The Journal of pathology.

[45]  Robert J. Lonigro,et al.  Integrative Clinical Genomics of Metastatic Cancer , 2017, Nature.

[46]  S. Filip,et al.  The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review , 2017, Clinical & Experimental Metastasis.

[47]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[48]  Krishnendu Chatterjee,et al.  Reconstructing metastatic seeding patterns of human cancers , 2017, Nature Communications.

[49]  Hans Clevers,et al.  Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.

[50]  P. Lønning,et al.  Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection , 2016, PLoS genetics.

[51]  Eric Talevich,et al.  CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing , 2016, PLoS Comput. Biol..

[52]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, bioRxiv.

[53]  Yoon Young Choi,et al.  Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: a case control study , 2015, BMC Cancer.

[54]  M. Stratton,et al.  Clock-like mutational processes in human somatic cells , 2015, Nature Genetics.

[55]  Robert T. Jones,et al.  Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. , 2015, Cancer discovery.

[56]  Jason G. Jin,et al.  Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes , 2015, Nature Medicine.

[57]  Charles Swanton,et al.  Translational Implications of Tumor Heterogeneity , 2015, Clinical Cancer Research.

[58]  D. Shin,et al.  Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. , 2014, The Lancet. Oncology.

[59]  S. Park,et al.  Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer , 2014, Gastric Cancer.

[60]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[61]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[62]  S. Natsugoe,et al.  Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[64]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[65]  Y. Ohashi,et al.  Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  C. Perou,et al.  Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.

[67]  Andrew Dunford,et al.  Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. , 2018, Cancer discovery.

[68]  Subramanian Venkatesan,et al.  Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[69]  Yoon Young Choi,et al.  Skip lymph node metastasis in gastric cancer: is it skipping or skipped? , 2015, Gastric Cancer.